Amivantamab: Prolonged Survivor in Post-TKI NSCLC with Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutation (ex20ins)
JOURNAL OF THORACIC ONCOLOGY（2023）
关键词
Non-Small-Cell Lung Cancer,EGFRex20ins,Amivantamab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要